Global Operation

Global Presence

Today, Drug International Limited is exporting its world class
pharmaceutical finished products to 14 countries.
At the age of globalization, the world has no boundaries. With the aim to cope with the challenges
of globalization, the company began export operations in 2002.
Currently, Drug International Limited is exporting a wide range of
pharmaceutical products under different therapeutic categories.
Drug International Limited has a portfolio that consists of
different types of products such as antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins and
minerals, cardiovascular, anti-diabetics, antihistamines, antipsychotics, etc. Apart from usual
tablets and capsules, DIL has technologically advanced dosage forms such as inhalers, lyophilized
injections, pre-filled syringes and sophisticated world class life saving oncology products. DIL is
also exporting different types of herbal products & supplements to many countries. Drug International Limited always thrives to introduce hi-tech &
innovative dosage forms for the betterment of our patients. Its state of the art facility is planned
and designed with fine tuned orientation to meet both local and international demands.
The mission of Drug International Limited has always been steered
by its philosophy of promoting "better life through better medicine". Hence, its efforts to improve
quality never stops. It continuously sets higher standards and has the passion to achieve it all.
WHO approved cGMP guidelines are strictly followed at every step during production. Each and every
member of the company is working persistently to uphold quality. The key purpose of Drug International Limited is to produce quality medication that
receives respect, recognition and practicing reference from the medical practitioners of the country
and now, abroad.
For its honest promise to society and the well-being of the global population, Drug International Limited never uses any harmful ingredients
while manufacturing its products. This is manifested clearly in its inhaler manufacturing facility.
It has established an ultra modern facility to manufacture inhaler products, which are completely
CFC free.
Drug International Limited's built-in Effluent Treatment Plant
(ETP) ensures environment-friendly pharmaceutical waste management practices.
To expedite its export mission, Drug International Limited
conducted bioequivalence studies on a variety of its products. These bioequivalence reports have
already been accepted by the regulatory bodies of several countries and thus, are helping export.
Drug International Limited also conducted clinical trials on its
products e.g. Gynomix Soft Capsule (Neomycin Sulphate BP 52mg, Polymyxin B Sulphate BP 5.50mg,
Nystatin BP 23mg & Metronidazole BP 200mg). More trials are in progress.
Drug International Limited is moving forward vigorously to increase
its market share in the operating countries and to explore new ones. A few African, Middle Eastern,
and Central American countries are under active search.